Health Officials Track Safety as COVID-19 Vaccines Roll Out

By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed to hang around after the injection in case signs of an allergy appear and they need immediate treatment — exactly what happened when the health worker in Juneau became flushed and short of breath 10 minutes after the shot. The second worker experienced eye puffiness, light headedness and scratchy throat. Allergies are always a question with a new medical product, but monitoring COVID-19 vaccines for any other, unexpected side effects is a bigger challenge than usual. It’s not just because so many people need to be vaccinated over the next year. Never before have so many vaccines made in different ways converged at the same time — and it’s possible that one shot option will come with different side effects than another. The first vaccine beginning widespread use in the U.S. and many Western countries, made by Pfizer Inc. and...
Source: JEMS Latest News - Category: Emergency Medicine Authors: Tags: AP News Coronavirus Source Type: news

Related Links:

"As pharmacists we have had to think outside the box in many ways during COVID-19, whether it is finding ways to do work remotely, curbside delivery, or dealing with COVID-related medication shortages."
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news
Millions of Medicaid enrollees risk losing their coverage when the COVID-19 public health emergency ends. What can be done to minimize this risk?       
Source: The Commonwealth Fund: Blog - Category: International Medicine & Public Health Authors: Source Type: blogs
The objective of this review was to analyze the existing data on acute inflammatory myelopathies associated with coronavirus disease 2019 infection, which were reported globally in 2020. PubMed, CENTRAL, MEDLINE, and online publication databases were searched. Thirty-three acute inflammatory myelopathy cases (among them, seven cases had associated brain lesions) associated with coronavirus disease 2019 infection were reported. Demyelinating change was seen in cervical and thoracic regions (27.3% each, separately). Simultaneous involvement of both regions, cervical and thoracic, was seen in 45.4% of the patients. Most acute...
Source: American Journal of Physical Medicine and Rehabilitation - Category: Rehabilitation Tags: SPECIAL SECTION on COVID-19 and PM&R Source Type: research
Advisers to top public health agency recommend against third jab for those in high-risk jobs
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
Provided no new variant emerges, former FDA chief Dr Scott Gottlieb, predicted Covid will become an endemic disease, meaning always present but transmitting at low rates.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Patient Care - Category: Emergency Medicine Authors: Tags: AP News Coronavirus Source Type: news
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Clinical Trials | Coronavirus | COVID-19 | Databases & Libraries | Education | Emergency Medicine | Headache | Health Management | Insurance | Migraine | Pandemics | Pfizer | Science | Shingles | Shingles (Herpes Zoster) Vaccine | Study | UK Health | Universities & Medical Training | Vaccines